Lataa...
Drug Company–Sponsored Patient Assistance Programs: A Viable Safety Net?
The benefits of drug company–sponsored PAPs remain unclear. Drug company–sponsored patient assistance programs (PAPs) provide access to brand-name medications at little or no cost and have been advocated as a safety net for inadequately insured patients. Yet little is known about these programs. We...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2873618/ https://ncbi.nlm.nih.gov/pubmed/19414893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.28.3.827 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|